Sign in

CIK 0001674416

  • Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
Operating
EIN
473173478
Phone
+1 617-315-4600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,881,673
in 7 filings, $1.5M under 10b5-1 plans

Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 60 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-10-26 Patel Naimish Chief Medical Officer Grant or award · Stock Option (Right to Buy) +24,000 24,000
2026-10-26 Patel Naimish Chief Medical Officer Grant or award · Restricted Stock Units +12,000 12,000
2026-05-29 Patel Naimish Chief Medical Officer Grant or award · Restricted Stock Units +22,000 22,000
2026-05-29 Patel Naimish Chief Medical Officer Sale −3,786 $55.62 $211K 19,357
2026-05-28 Patel Naimish Chief Medical Officer Option exercise +10,000 23,143
2026-05-28 Patel Naimish Chief Medical Officer Option exercise · Restricted Stock Units −10,000 20,000
2026-03-20 Patel Naimish Chief Medical Officer Grant or award · Stock Option (Right to Buy) +38,499 38,499
2026-03-20 Patel Naimish Chief Medical Officer Grant or award · Restricted Stock Units +30,000 30,000
2026-03-16 Patel Naimish Chief Medical Officer Sale −3,150 $48.26 $152K 13,143
2026-03-14 Patel Naimish Chief Medical Officer Option exercise +8,125 16,293
2026-03-14 Patel Naimish Chief Medical Officer Option exercise · Restricted Stock Units −8,125 24,375
2025-10-03 Patel Naimish Chief Medical Officer Grant or award · Stock Option (Right to Buy) +16,500 16,500
2025-05-30 Patel Naimish Chief Medical Officer Grant or award · Restricted Stock Units +25,000 25,000
2025-05-29 Patel Naimish Chief Medical Officer Sale −3,932 $35.94 $141K 6,068
2025-05-28 Patel Naimish Chief Medical Officer Option exercise +10,000 10,000
2025-05-28 Patel Naimish Chief Medical Officer Option exercise · Restricted Stock Units −10,000 30,000
2025-04-03 Patel Naimish Chief Medical Officer Purchase +1,508 $32.96 $50K 1,508
2025-03-14 Patel Naimish Chief Medical Officer Grant or award · Stock Option (Right to Buy) +46,667 46,667
2025-03-14 Patel Naimish Chief Medical Officer Grant or award · Restricted Stock Units +32,500 32,500
2024-10-16 Patel Naimish Chief Medical Officer Grant or award · Stock Option (Right to Buy) +18,333 18,333

Page 1 of 2 · 22 trades